INSERM - Institut National de la Santé et de la Recherche Médicale : U1228, Inria Rennes – Bretagne Atlantique , IRISA-D5 - SIGNAUX ET IMAGES NUMÉRIQUES, ROBOTIQUE
IMT Atlantique - IMT Atlantique Bretagne-Pays de la Loire (Campus Brest : Technopôle Brest-Iroise CS 8381829238 BREST Cedex 3 -
Campus Nantes : 4, rue Alfred Kastler- La chantrerie 44300 NANTES -
Campus Rennes : 2 Rue de la Châtaigneraie, 35510 CESSON SEVIGNE - France)
Abstract : The therapeutic arsenal for preventing multiple sclerosis (MS) relapses strongly improved over the last 20 years with more than 10 disease-modifying drugs now available. However, relapses can still occur, requiring treatment with corticosteroids to accelerate recovery...
https://hal-univ-rennes1.archives-ouvertes.fr/hal-01559941
Contributor : Laurent Jonchère
<>
Submitted on : Tuesday, July 11, 2017 - 9:56:15 AM
Last modification on : Friday, September 13, 2019 - 9:50:02 AM
Emmanuelle Le Page, Gilles Edan. Oral rather than intravenous corticosteroids should be used to treat MS relapses - Yes. Multiple Sclerosis, SAGE Publications, 2017, 23 (8), pp.1056--1058. ⟨10.1177/1352458517695893⟩. ⟨hal-01559941⟩
